[1]
Alobaidi, Z.A. and Mohammed, S.I. 2023. Association of Disease Duration and Duration of Olanzapine Use with Blood Sugar, Blood Pressure, BMI, and Lipid Profile among Schizophrenic Patients in Iraq. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 4, (Jun. 2023), 79–85. DOI:https://doi.org/10.54133/ajms.v4i.119.